almitrine has been researched along with Lung Diseases, Obstructive in 108 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 82 (75.93) | 18.7374 |
1990's | 24 (22.22) | 18.2507 |
2000's | 2 (1.85) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hallemans, R; Mélot, C; Mertens, P; Mols, P; Naeije, R; Rothschild, T | 1 |
Campbell, EJ; Mahood, CB; Powles, AC; Pugsley, SO; Tuxen, DV | 1 |
Cover, D; Davies, EE; Hughes, JM; Nicholl, CG; Pride, NB; Stradling, JR | 2 |
Chrétien, J | 1 |
Bromet, N; Singlas, E | 1 |
Castaing, Y; Guenard, H; Manier, G | 3 |
Prefaut, C | 1 |
Noseda, A; Paiva, M; Ravez, P; Van Muylem, A; Yernault, JC | 1 |
Sadoul, P | 1 |
Pauly, N; Pieczora, JA; Stanley, NN | 1 |
Bogaert, E; de Backer, W; Van Maele, R; Vermeire, P | 1 |
Beaufils, F; Boule, M; Gaultier, C; Mercier, JC | 1 |
Bourgouin-Karaouni, D; Macabies, J; Michel, FB; Prefaut, C; Ramonatxo, M | 2 |
Hallemans, R; Lejeune, P; Melot, C; Mols, P; Naeije, R | 1 |
Pariente, R | 1 |
Campbell, DB; Gordon, B; Taylor, A; Taylor, D; Williams, J | 1 |
Aubert, Y; Balem, MP; Baune, A; Bromet, N; Courte, S; du Vignaud, P | 1 |
Huchon, G | 1 |
Cornil, A; Hallemans, R; Mélot, C; Mols, P; Naeije, N; Naeije, R; Sergysels, R | 1 |
Gonzales, C; Michel, FB; Préfaut, C; Seignalet, C | 1 |
Popowycz, W; Vander Eecken, H; Verstraeten, JM | 1 |
Aubert, Y; Baune, A; Bromet, N; Courte, S; Guillaudeux, J | 1 |
Arnaud, A; Barret, A; Levy, S; Philip-Joët, F; Saadjian, A | 1 |
Izquierdo, J; Morera, J | 1 |
Arnaud, AG; Barret, A; Levy, S; Philip-Jöel, FF; Saadjian, AY | 1 |
Kneissl, DG; Kronenberger, H; Kullmer, TH; Trenk, D; Winkelmann, BR | 1 |
González Ruiz, JM; Lobato, SD; Muñoz, J; Pino, JM; Prados, C; Villamor, J | 1 |
Bardsley, PA | 1 |
Celdrán Gil, J; Durán Pérez-Navarro, A; Hernández Lanchas, C; Marcos Sánchez, F; Santurino Martín, JA | 1 |
González-Ruiz, JM | 1 |
Jardim, JR; Nery, LE; Novo, NF; Ribeiro, SA; Romaldini, H | 1 |
Magnussen, H; Nowak, D; Wywiol, A | 1 |
Voisin, C | 1 |
Criée, C; Köhler, D; Raschke, F | 1 |
McNicholas, WT | 1 |
Orehek, J; Pinet, C; Ravel, T; Tessonnier, F | 1 |
Arnaud, F; Bardsley, PA; Empey, D; Harrison, B; Howard, P; O'Reilly, J; Peake, MD; Riordan, JF; Tang, O; Wilkinson, J | 1 |
Arnaud, F; Bignon, J; Boutin, C; Brune, J; Castaing, Y; Courty, G; Derenne, J; Duroux, P; Fréour, P; Weitzenblum, E | 1 |
Apprill, M; Prefaut, C; Schrijen, F; Weitzenblum, E; Yernault, JC | 1 |
Ansquer, J; Bardsley, PA; Bury, T; DeBacker, W; Howard, P; Ledent, C; Mairesse, M; Radermecker, M; Vermeire, P | 1 |
Bardsley, PA; Howard, P; Morgan, N; Tweney, J | 1 |
Matthay, RA; Wiedemann, HP | 1 |
Böhning, W; Breuer, HW; Brüch, M; Müller-Höhl, ML; Nikolaus, J; Wettengel, R; Winkelmann, B; Worth, H | 1 |
Cai, YY; Niu, SF; Xu, FP | 1 |
Apprill, M; Kurtz, D; Oswald, M; Weitzenblum, E | 1 |
Daskalopoulou, E; Maniki, E; Patakas, D; Tsara, V; Zoglopitis, F | 1 |
López Alvarez, M; Rubio Terrés, C; Vargas Castrillón, E | 1 |
Bakran, I; Ivicevic, A; Kandare, F; Stangl, B; Tabori, D; Todic, V; Vrhovac, B | 1 |
Ansquer, JC; Bury, T; Jeannot, JP; Radermecker, M | 1 |
Howard, P | 1 |
Ansquer, JC; Clark, MJ; Le Merre, C; Préfaut, C; Zouari, N | 1 |
Bachand, RT; Cutillo, AG; Kanner, RE; Menlove, RL; Renzetti, AD; Szalkowski, MB; Watanabe, S | 1 |
Arnaud, F; David, P; Lerebours, G; Moore, N; Nouvet, G; Ozenne, G; Senant, J | 1 |
Benvenuti, C; Degos, JD; Gherardi, R; Lejonc, JL; Louarn, F; Perrier, M; Schaeffer, A | 1 |
Huber, G; Köhler, D; Matthys, H; Rühle, KH | 1 |
Howard, P; Jarratt, JA; Proctor, A; Suggett, AJ | 1 |
Cover, D; Hughes, JM; Maxwell, DL | 1 |
Denjean, A; Harf, A; Meignan, M; Prost, JF; Raffestin, B; Simonneau, G | 1 |
Krieger, J; Kurtz, D; Reitzer, B; Roujansky, P; Weitzenblum, E | 1 |
Blasi, A; Bottino, G; Grassi, C; Grassi, V | 1 |
Lagneaux, D; Lecomte, J | 1 |
Patz, D | 1 |
Akiyama, Y; Kawakami, Y | 1 |
Barnes, PJ; Chung, KF | 1 |
Bachand, RT; Bianco, KA; Cherniack, NS; Gothe, B; Szalkowski, MB | 1 |
Ham, H; Michel, O; Sergysels, R | 1 |
Apprill, M; Kessler, R; Krieger, J; Kurtz, D; Weitzenblum, E | 1 |
Hillebrand, M; Siemon, G | 1 |
Arnaud, F; Lerebours, G; Moore, N; Nouvet, G; Senant, J | 1 |
Ansquer, JC | 3 |
Costabel, U; Kempf, P; Klein, G; Matthys, H; Mössinger, B; Rühle, KH; Würtemberger, G | 1 |
Duroux, P; Hervé, P; Simonneau, G | 1 |
Nielsen, SP | 1 |
Bellone, A; Castelli, T; Damato, S; Daniele, R; Mendoza, M | 1 |
Amarenco, G; Chedru, F; Ciaudo-Lacroix, C; Dunand, JF; Ghnassia, R; Nodzenski, R; Said, G | 1 |
Couturier, JC; Gerard, M; Leger, P; Robert, D | 1 |
Feist, H | 1 |
Bourgouin-Karaouni, D; Mercier, J; Prefaut, C | 1 |
Bury, T; Radermecker, M | 1 |
González Montaner, LJ | 1 |
Tweney, J | 1 |
Ansquer, JC; Howard, P; Voisin, C | 1 |
Raimondi, GA | 1 |
Bachand, RT; Bell, RC; Johanson, WG; Mullins, RC; West, LG | 1 |
Blasi, A; Bottino, G; Cerveri, I; Giacometti, A; Grassi, C; Grassi, V; Pezza, A; Rampulla, C; Sorbini, CA; Tantucci, C | 1 |
Carnimeo, N; Chianese, R; Dardes, N; Maiorano, V; Moreo, GC; Vulterini, S | 1 |
Gotz, VP; Ryerson, GG; Smith, PD | 1 |
Hubert, P; Meslier, N; Racineux, JL | 1 |
Daskalopoulou, E; Kazis, A; Maniki, E; Patakas, D; Tsara, V; Zoglopitis, F | 1 |
Cerveri, I; Grassi, C; Grassi, V; Rampulla, C; Tantucci, C | 1 |
Kiwull-Schöne, H; Magnussen, H; Radenbach, D | 1 |
Barer, G; Bee, D; Gill, GW; Suggett, AJ; Wach, RA | 1 |
Hubert, P; Meslier, N; Monrigal, JP; Racineux, JL | 1 |
Duroux, P | 1 |
Bourgouin-Karaouni, D; Préfaut, C | 2 |
Magnussen, H | 1 |
Miech, G; Seignalet, C | 1 |
Bogaert, E; De Backer, W; Janssen, E; Van Maele, R; Vermeire, P | 1 |
12 review(s) available for almitrine and Lung Diseases, Obstructive
Article | Year |
---|---|
The hypoxaemia in chronic obstructive pulmonary disease (COPD) and its management.
Topics: Almitrine; Humans; Hypoxia; Lung Diseases, Obstructive; Oxygen; Respiratory System Agents; Survival Rate | 1998 |
Impact of sleep in COPD.
Topics: Adrenergic beta-Agonists; Almitrine; Carbon Dioxide; Cholinergic Antagonists; Humans; Lung Diseases, Obstructive; Oxygen; Positive-Pressure Respiration; Sleep Apnea, Obstructive; Sleep, REM; Theophylline; Ventilation-Perfusion Ratio | 2000 |
Cor pulmonale in chronic obstructive pulmonary disease. Circulatory pathophysiology and management.
Topics: Adrenergic beta-Agonists; Almitrine; Bloodletting; Digitalis Glycosides; Humans; Lung Diseases, Obstructive; Pulmonary Circulation; Pulmonary Heart Disease; Theophylline; Vasodilator Agents | 1990 |
Drug therapy of sleep-related hypoxaemia.
Topics: Almitrine; Humans; Hypoxia; Lung Diseases, Obstructive; Medroxyprogesterone; Medroxyprogesterone Acetate; Oxygen Inhalation Therapy; Sleep Apnea Syndromes | 1990 |
[Almitrine: a peripheral respiratory stimulant in chronic obstructive pulmonary disease].
Topics: Almitrine; Humans; Lung Diseases, Obstructive; Peripheral Nervous System Diseases | 1990 |
Hypoxia, almitrine, and peripheral neuropathy.
Topics: Almitrine; Humans; Hypoxia; Lung Diseases, Obstructive; Peripheral Nervous System Diseases; Piperazines | 1989 |
[Are respiratory stimulants necessary? No].
Topics: Almitrine; Central Nervous System Stimulants; Chemoreceptor Cells; Doxapram; Humans; Lung Diseases, Obstructive; Piperazines; Respiration; Respiratory Center; Respiratory Insufficiency | 1987 |
Respiratory and allergic disease. II. Chronic obstructive airways disease and respiratory infections.
Topics: Almitrine; Anti-Bacterial Agents; Antitubercular Agents; Central Nervous System Stimulants; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Piperazines; Respiratory Tract Infections; Vasodilator Agents | 1988 |
[The effect of almitrine dimesylate on pulmonary hemodynamics in healthy subjects and in patients with chronic obstructive bronchitis].
Topics: Almitrine; Central Nervous System Stimulants; Hemodynamics; Humans; Lung Diseases, Obstructive; Piperazines; Pulmonary Circulation | 1988 |
Almitrine bismesylate: current status.
Topics: Almitrine; Animals; Humans; Lung Diseases, Obstructive; Piperazines; Respiration | 1987 |
Almitrine bismesylate.
Topics: Adult; Aged; Almitrine; Chemoreceptor Cells; Clinical Trials as Topic; Double-Blind Method; Humans; Kinetics; Lung Diseases, Obstructive; Middle Aged; Piperazines; Respiratory Insufficiency | 1987 |
[Almitrine dimesylate: ventilatory or vascular action].
Topics: Almitrine; Animals; Blood Pressure; Blood Vessels; Chemoreceptor Cells; Dogs; Hemodynamics; Humans; Lung; Lung Diseases, Obstructive; Piperazines; Pulmonary Circulation; Pulmonary Gas Exchange; Respiration; Vasodilator Agents | 1985 |
57 trial(s) available for almitrine and Lung Diseases, Obstructive
Article | Year |
---|---|
The effect of intravenously administered almitrine, a peripheral chemoreceptor agonist, on patients with chronic air-flow obstruction.
Topics: Almitrine; Blood Gas Analysis; Central Nervous System Stimulants; Female; Humans; Infusions, Parenteral; Lung Diseases, Obstructive; Male; Middle Aged; Piperazines; Placebos | 1983 |
The effects of oral almitrine on pattern of breathing and gas exchange in patients with chronic obstructive pulmonary disease.
Topics: Administration, Oral; Aged; Almitrine; Central Nervous System Stimulants; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen; Piperazines; Pulmonary Gas Exchange; Respiration | 1984 |
[Influence of almitrine dimesylate on gas exchange. Preliminary results in patients with chronic obstructive bronchopneumopathies under artificial ventilation].
Topics: Almitrine; Central Nervous System Stimulants; Hemodynamics; Humans; Lung Diseases, Obstructive; Piperazines; Pulmonary Gas Exchange; Respiration, Artificial; Ventilation-Perfusion Ratio | 1984 |
Pattern of breathing and gas exchange following oral almitrine bismesylate in patients with chronic obstructive pulmonary disease.
Topics: Administration, Oral; Aged; Almitrine; Clinical Trials as Topic; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Piperazines; Pulmonary Gas Exchange; Respiration; Ventilation-Perfusion Ratio | 1983 |
Effect of almitrine bismesylate on the distribution of ventilation and mechanics of breathing in patients with COLD.
Topics: Almitrine; Clinical Trials as Topic; Double-Blind Method; Humans; Lung Diseases, Obstructive; Lung Volume Measurements; Piperazines; Ventilation-Perfusion Ratio | 1983 |
Vectarion International Multicentre Study (VIMS): a long term double blind placebo controlled trial in COLD patients.
Topics: Adult; Aged; Almitrine; Clinical Trials as Topic; Double-Blind Method; Europe; Humans; International Cooperation; Lung Diseases, Obstructive; Middle Aged; Piperazines | 1983 |
Effects of almitrine bismesylate on chemosensitivity in patients with chronic airways obstruction.
Topics: Almitrine; Carbon Dioxide; Chemoreceptor Cells; Humans; Lung Diseases, Obstructive; Oxygen; Piperazines | 1983 |
Effects of almitrine in decompensated chronic respiratory insufficiency.
Topics: Aged; Almitrine; Chronic Disease; Clinical Trials as Topic; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Infusions, Parenteral; Lung Diseases, Obstructive; Male; Middle Aged; Piperazines; Respiration; Ventilation-Perfusion Ratio | 1981 |
[Almitrine per os in the therapy of chronic obstructive bronchopneumopathies].
Topics: Administration, Oral; Almitrine; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Piperazines | 1980 |
Nifedipine inhibits the effects of almitrine in patients suffering from pulmonary artery hypertension secondary to chronic obstructive pulmonary disease.
Topics: Almitrine; Blood Gas Analysis; Cardiac Catheterization; Double-Blind Method; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Male; Middle Aged; Nifedipine; Pulmonary Circulation; Respiratory Function Tests; Respiratory Mechanics; Vasoconstriction; Vasodilation | 1993 |
Effect of almitrine bismesylate on pulmonary vasoreactivity to hypoxia in chronic obstructive pulmonary disease.
Topics: Almitrine; Carbon Dioxide; Double-Blind Method; Female; Hemodynamics; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen; Oxygen Consumption; Pulmonary Circulation; Vasomotor System | 1994 |
Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary disease.
Topics: Administration, Oral; Aged; Almitrine; Carbon Dioxide; Female; Humans; Hypoxia; Infusions, Intravenous; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen; Respiratory Mechanics | 1994 |
[The predictive parameters in the response to almitrine treatment].
Topics: Aged; Almitrine; Analysis of Variance; Bronchitis; Double-Blind Method; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Prognosis; Respiratory Function Tests; Respiratory Insufficiency | 1994 |
Effects of almitrine on the ventilatory control, breathing pattern and maximal exercise tolerance in hypoxemic patients with chronic obstructive pulmonary disease.
Topics: Adult; Aged; Almitrine; Blood Gas Analysis; Double-Blind Method; Exercise; Humans; Hypoxia; Lung Diseases, Obstructive; Male; Maximal Voluntary Ventilation; Middle Aged; Respiratory System Agents | 1995 |
[Almitrine in therapy of chronic obstructive respiratory tract diseases with hypoxemia--a clinical multicenter study comparing 2 dosages].
Topics: Aged; Almitrine; Dose-Response Relationship, Drug; Female; Forced Expiratory Volume; Humans; Hypoxia; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen; Prospective Studies; Respiratory System Agents; Treatment Outcome | 1998 |
[Almitrin and patients with COPD--a dangerous combination?].
Topics: Almitrine; Humans; Lung Diseases, Obstructive; Respiratory System Agents; Treatment Failure | 1998 |
Association of oral almitrine and medroxyprogesterone acetate: effect on arterial blood gases in chronic obstructive pulmonary disease.
Topics: Aged; Almitrine; Blood Gas Analysis; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Humans; Lung Diseases, Obstructive; Male; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Respiratory System Agents; Statistics, Nonparametric; Treatment Outcome | 2001 |
Sequential treatment with low dose almitrine bismesylate in hypoxaemic chronic obstructive airways disease.
Topics: Adult; Aged; Almitrine; Body Weight; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypoxia; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen | 1992 |
[Sequential administration of a reduced dose of almitrine to patients with chronic obstructive bronchopneumopathies. A controlled multicenter study].
Topics: Adult; Aged; Almitrine; Electrophysiology; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Peripheral Nerves; Respiratory Function Tests; Time Factors | 1992 |
One year treatment with almitrine improves hypoxaemia but does not increase pulmonary artery pressure in COPD patients.
Topics: Adult; Aged; Almitrine; Blood Pressure; Cardiac Output; Double-Blind Method; Humans; Hypoxia; Lung Diseases, Obstructive; Middle Aged; Oxygen; Pulmonary Artery; Respiratory Mechanics; Time Factors; Vascular Resistance | 1991 |
Two years treatment with almitrine bismesylate in patients with hypoxic chronic obstructive airways disease.
Topics: Almitrine; Carbon Dioxide; Double-Blind Method; Female; Humans; Hypoxia; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen | 1991 |
Oral almitrine in treatment of acute respiratory failure and cor pulmonale in patients with an exacerbation of chronic obstructive airways disease.
Topics: Administration, Oral; Aged; Aged, 80 and over; Almitrine; Carbon Dioxide; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen; Pulmonary Heart Disease; Respiratory Insufficiency; Vital Capacity | 1991 |
[Long-term therapy with almitrine dimesilate has no effect on pulmonary hemodynamics at rest and during stress].
Topics: Almitrine; Double-Blind Method; Exercise Test; Female; Hemodynamics; Humans; Long-Term Care; Lung Diseases, Obstructive; Male; Middle Aged; Pulmonary Circulation; Randomized Controlled Trials as Topic; Respiratory Insufficiency | 1990 |
Comparison of almitrine bismesylate and medroxyprogesterone acetate on oxygenation during wakefulness and sleep in patients with chronic obstructive lung disease.
Topics: Almitrine; Carbon Dioxide; Chemoreceptor Cells; Humans; Lung Diseases, Obstructive; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Oxygen; Pulmonary Ventilation; Sleep; Spirometry; Wakefulness | 1990 |
Double-blind placebo controlled clinical trial of almitrine bismesylate in patients with chronic respiratory insufficiency.
Topics: Adult; Aged; Almitrine; Bronchitis; Chronic Disease; Double-Blind Method; Emphysema; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Randomized Controlled Trials as Topic; Respiratory Function Tests | 1990 |
Dose-response and pharmacokinetic study with almitrine bismesylate after single oral administrations in COPD patients.
Topics: Aged; Almitrine; Carbon Dioxide; Dose-Response Relationship, Drug; Half-Life; Humans; Hypoxia; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen; Piperazines | 1989 |
Is the mode of action of almitrine bismesylate dose dependent?
Topics: Administration, Oral; Aged; Almitrine; Dose-Response Relationship, Drug; Humans; Lung Diseases, Obstructive; Male; Pulmonary Gas Exchange; Random Allocation | 1989 |
Long-term effect of almitrine bismesylate in patients with hypoxemic chronic obstructive pulmonary disease.
Topics: Adult; Aged; Almitrine; Altitude; Body Weight; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypoxia; Lung Diseases, Obstructive; Male; Middle Aged; Paresthesia; Time Factors | 1989 |
[Nocturnal hypoxemia and hypercapnia in patients with chronic obstructive ventilation disorder. Therapy with almitrine, a peripheral chemoreceptor stimulator].
Topics: Aged; Almitrine; Carbon Dioxide; Central Nervous System Stimulants; Clinical Trials as Topic; Female; Humans; Hypercapnia; Hypoxia; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen; Partial Pressure; Piperazines | 1985 |
Almitrine and peripheral neuropathy.
Topics: Aged; Almitrine; Central Nervous System Stimulants; Humans; Lung Diseases, Obstructive; Middle Aged; Peripheral Nervous System Diseases; Piperazines; Respiratory Insufficiency | 1985 |
Almitrine increases the steady-state hypoxic ventilatory response in hypoxic chronic air-flow obstruction.
Topics: Aged; Almitrine; Blood Gas Analysis; Carbon Dioxide; Central Nervous System Stimulants; Double-Blind Method; Humans; Hypoxia; Lung Diseases, Obstructive; Male; Middle Aged; Piperazines; Plethysmography; Random Allocation; Respiration | 1985 |
Cardiopulmonary effects of a single oral dose of almitrine at rest and on exercise in patients with hypoxic chronic airflow obstruction.
Topics: Administration, Oral; Adult; Aged; Almitrine; Central Nervous System Stimulants; Clinical Trials as Topic; Double-Blind Method; Hemodynamics; Humans; Lung Diseases, Obstructive; Middle Aged; Physical Exertion; Piperazines; Pulmonary Gas Exchange; Random Allocation; Respiration | 1986 |
[Sleep and nocturnal desaturation of patients with chronic obstructive bronchopneumopathies. Effects of almitrine bismesylate administered orally].
Topics: Administration, Oral; Almitrine; Central Nervous System Stimulants; Humans; Hypoxia; Lung Diseases, Obstructive; Piperazines; Pulmonary Gas Exchange; Sleep | 1985 |
[The first Italian clinical experience with almitrine bismesylate].
Topics: Almitrine; Central Nervous System Stimulants; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Drug Tolerance; Female; Humans; Hypoxia; Italy; Lung Diseases, Obstructive; Male; Oxygen Consumption; Piperazines; Pulmonary Gas Exchange; Random Allocation | 1985 |
Long-term effects of almitrine bismesylate on oxygenation during wakefulness and sleep in chronic obstructive pulmonary disease.
Topics: Adult; Almitrine; Central Nervous System Stimulants; Clinical Trials as Topic; Double-Blind Method; Humans; Hypoxia; Lung Diseases, Obstructive; Male; Middle Aged; Piperazines; Random Allocation; Sleep; Time Factors; Wakefulness | 1988 |
A one year double blind follow-up of blood gas tensions and haemodynamics in almitrine bismesylate therapy.
Topics: Aged; Almitrine; Analysis of Variance; Carbon Dioxide; Central Nervous System Stimulants; Clinical Trials as Topic; Double-Blind Method; Female; Hemodynamics; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen; Partial Pressure; Piperazines; Pulmonary Wedge Pressure; Random Allocation | 1988 |
[Effect of almitrine, a chemoreceptor stimulator, on nocturnal hypercapnia and pulmonary artery pressure during O2 respiration in chronic obstructive lung disease].
Topics: Aged; Almitrine; Blood Pressure; Central Nervous System Stimulants; Humans; Hypercapnia; Lung Diseases, Obstructive; Middle Aged; Oxygen; Oxygen Inhalation Therapy; Partial Pressure; Piperazines; Pulmonary Artery | 1988 |
[Almitrine bismesylate. A peripheral chemoreceptor agonist].
Topics: Almitrine; Central Nervous System Stimulants; Chemoreceptor Cells; Clinical Trials as Topic; Humans; Lung Diseases, Obstructive; Piperazines | 1988 |
Breathing pattern--gas exchange relation and acute effect of almitrine in severe chronic airflow obstruction.
Topics: Almitrine; Central Nervous System Stimulants; Clinical Trials as Topic; Double-Blind Method; Exercise; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Piperazines; Pulmonary Gas Exchange; Random Allocation; Respiration; Tidal Volume | 1988 |
Improvement in ventilation-perfusion relationships by almitrine in patients with chronic obstructive pulmonary disease during mechanical ventilation.
Topics: Almitrine; Blood Gas Analysis; Carbon Dioxide; Humans; Lung Diseases, Obstructive; Noble Gases; Oxygen; Piperazines; Pulmonary Alveoli; Respiration, Artificial; Ventilation-Perfusion Ratio | 1986 |
Long term studies on almitrine bismesylate in COPD patients.
Topics: Almitrine; Carbon Dioxide; Humans; Lung Diseases, Obstructive; Oxygen; Piperazines; Time Factors | 1986 |
[Role of almitrine in the treatment of chronic obstructive bronchopneumopathy].
Topics: Almitrine; Clinical Trials as Topic; Humans; Lung Diseases, Obstructive; Neuritis; Piperazines; Pulmonary Gas Exchange | 1987 |
[Treatment of hematosis disorders in chronic obstructive bronchitis with almitrine bismesylate].
Topics: Almitrine; Animals; Blood Gas Analysis; Clinical Trials as Topic; Dogs; Female; Humans; Lung Diseases, Obstructive; Male; Piperazines; Pulmonary Gas Exchange; Respiratory Insufficiency; Ventilation-Perfusion Ratio | 1986 |
Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group.
Topics: Administration, Oral; Adult; Aged; Almitrine; Blood Gas Analysis; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Lung Diseases, Obstructive; Male; Maximal Expiratory Flow Rate; Middle Aged; Piperazines; Pulmonary Gas Exchange; Random Allocation; Spirometry; Vital Capacity | 1987 |
The effect of almitrine bismesylate on hypoxemia in chronic obstructive pulmonary disease.
Topics: Adult; Aged; Almitrine; Clinical Trials as Topic; Double-Blind Method; Dyspnea; Female; Humans; Hypoxia; Lung Diseases, Obstructive; Male; Middle Aged; Piperazines; Respiratory Function Tests | 1986 |
A review of clinical studies carried out in Italy with almitrine bismesylate.
Topics: Almitrine; Clinical Trials as Topic; Female; Humans; Hypoxia; Italy; Lung Diseases, Obstructive; Male; Middle Aged; Piperazines | 1986 |
Almitrine bismesylate and hypoxemia in COPD patients (results of an Italian multicentric trial).
Topics: Aged; Almitrine; Clinical Trials as Topic; Female; Humans; Hypoxia; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen; Piperazines | 1986 |
A one-year double-blind placebo-controlled study of the efficacy and safety of almitrine bismesylate in hypoxic COLD patients. Monitoring progress status on 490 patients entered into the VIMS study before January 1st, 1984.
Topics: Adult; Aged; Almitrine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypoxia; Lung Diseases, Obstructive; Male; Middle Aged; Piperazines; Time Factors | 1986 |
Almitrine bismesylate.
Topics: Adult; Aged; Almitrine; Chemoreceptor Cells; Clinical Trials as Topic; Double-Blind Method; Humans; Kinetics; Lung Diseases, Obstructive; Middle Aged; Piperazines; Respiratory Insufficiency | 1987 |
The effect of long-term almitrine therapy on sleep hypoxaemia in patients with chronic airways obstruction.
Topics: Administration, Oral; Almitrine; Double-Blind Method; Drug Evaluation; Female; Humans; Hypoxia; Lung Diseases, Obstructive; Male; Middle Aged; Piperazines; Random Allocation; Sleep; Ventilation-Perfusion Ratio | 1987 |
Almitrine effect on nocturnal hypoxaemia in patients with chronic obstructive pulmonary disease (COPD).
Topics: Administration, Oral; Aged; Almitrine; Double-Blind Method; Drug Evaluation; Forced Expiratory Flow Rates; Humans; Hypoxia; Lung Diseases, Obstructive; Middle Aged; Oxygen; Piperazines; Residual Volume; Sleep Stages; Total Lung Capacity; Vital Capacity | 1987 |
Influence of the carotid body on gas exchange during exercise.
Topics: Aged; Almitrine; Carotid Body; Chemoreceptor Cells; Female; Humans; Lung Diseases, Obstructive; Lung Volume Measurements; Male; Middle Aged; Physical Exertion; Piperazines; Respiration | 1987 |
The acute effect of a single oral dose of 200 mg almitrine on gas exchange in patients with chronic obstructive bronchitis and emphysema, bronchial asthma and lung fibrosis.
Topics: Administration, Oral; Adult; Aged; Almitrine; Asthma; Blood Gas Analysis; Double-Blind Method; Drug Evaluation; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Piperazines; Pulmonary Fibrosis; Pulmonary Gas Exchange; Random Allocation | 1987 |
[Vectarian international multicenter study (VIMS) in hypoxemic chronic bronchitis patients treated by the double-blind placebo method for 1 year. Follow-up of the monitoring of 490 patients].
Topics: Aged; Almitrine; Bronchitis; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypoxia; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen; Piperazines | 1985 |
[Effect of almitrine and oxygen on arterial blood gases in chronic respiratory insufficiency].
Topics: Almitrine; Carbon Dioxide; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Hydrogen-Ion Concentration; Lung Diseases, Obstructive; Oxygen; Oxygen Inhalation Therapy; Partial Pressure; Piperazines; Pulmonary Emphysema; Pulmonary Fibrosis | 1985 |
[Value of almitrine dimesylate in the long-term treatment of chronic obstructive bronchitis].
Topics: Adult; Aged; Almitrine; Bronchitis; Carbon Dioxide; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen; Piperazines | 1985 |
[Effect of almitrine dimesylate on blood gases in chemodenervated patients with chronic obstructive bronchopneumopathy].
Topics: Almitrine; Carbon Dioxide; Carotid Body; Clinical Trials as Topic; Denervation; Double-Blind Method; Humans; Lung Diseases, Obstructive; Oxygen; Piperazines | 1985 |
40 other study(ies) available for almitrine and Lung Diseases, Obstructive
Article | Year |
---|---|
Improvement in ventilation-perfusion matching by almitrine in COPD.
Topics: Administration, Oral; Aged; Almitrine; Carbon Dioxide; Central Nervous System Stimulants; Hemodynamics; Humans; Lung; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen; Piperazines; Pulmonary Circulation; Ventilation-Perfusion Ratio | 1983 |
[Chronic bronchopneumopathies. A new therapeutic approach].
Topics: Almitrine; Central Nervous System Stimulants; Humans; Lung Diseases, Obstructive; Piperazines | 1984 |
[Clinical pharmacokinetics of almitrine dimesylate].
Topics: Adult; Aged; Almitrine; Biological Availability; Bronchitis; Central Nervous System Stimulants; Chemical Phenomena; Chemistry, Physical; Female; Food; Humans; Kidney Failure, Chronic; Kinetics; Liver Diseases; Lung Diseases, Obstructive; Male; Middle Aged; Piperazines; Serum Albumin; Time Factors | 1984 |
[Should arterial gas values be improved in patients with chronic bronchitic respiratory insufficiency? Value of almitrine dimesylate].
Topics: Almitrine; Animals; Blood Gas Analysis; Central Nervous System Stimulants; Dogs; Humans; Lung Diseases, Obstructive; Piperazines; Prognosis; Respiratory Insufficiency | 1984 |
Effect of almitrine bismesylate on arterial blood gases and ventilatory drive in patients with severe chronic airflow obstruction and bilateral carotid body resection.
Topics: Aged; Almitrine; Carbon Dioxide; Carotid Body; Combined Modality Therapy; Double-Blind Method; Female; Humans; Lung Diseases, Obstructive; Male; Oxygen; Piperazines; Pulmonary Gas Exchange | 1983 |
Lung function after almitrine bismesylate administration in a five year old boy with chronic airways obstruction.
Topics: Almitrine; Carbon Dioxide; Child, Preschool; Humans; Lung Diseases, Obstructive; Male; Oxygen; Piperazines; Respiration | 1983 |
[Pulmonary hemodynamic monitoring in chronic respiratory insufficiency treated with almitrine bismesilate for 4 months in a double-blind study].
Topics: Adult; Aged; Almitrine; Analysis of Variance; Cardiac Output; Double-Blind Method; Hemodynamics; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Piperazines; Pulmonary Gas Exchange; Pulmonary Wedge Pressure | 1984 |
VA/Q ratios distribution and oral almitrine bismesylate in COPD patients under mechanical ventilation: preliminary results.
Topics: Almitrine; Humans; Lung Diseases, Obstructive; Piperazines; Respiration, Artificial; Respiratory Insufficiency; Ventilation-Perfusion Ratio | 1983 |
Beneficial effects of almitrine bismesylate on pulmonary gas exchange in COPD.
Topics: Aged; Almitrine; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Piperazines; Pulmonary Gas Exchange; Ventilation-Perfusion Ratio | 1983 |
Clinical pharmacology of almitrine bismesylate.
Topics: Almitrine; Humans; Lung Diseases, Obstructive; Piperazines; Pulmonary Circulation; Ventilation-Perfusion Ratio | 1983 |
The biodisposition of almitrine bismesylate in man: a review.
Topics: Almitrine; Biological Availability; Half-Life; Humans; Lung Diseases, Obstructive; Metabolic Clearance Rate; Piperazines | 1983 |
Pharmacokinetics of almitrine bismesylate: studies in patients.
Topics: Adult; Aged; Almitrine; Biological Availability; Female; Humans; Kidney Failure, Chronic; Kinetics; Liver Cirrhosis; Lung Diseases, Obstructive; Male; Middle Aged; Piperazines | 1983 |
Advances in treatment of chronic obstructive lung disease with almitrine bis-mesylate.
Topics: Almitrine; Animals; Cats; Dogs; Humans; Lung Diseases, Obstructive; Piperazines; Rabbits; Rats; Respiration; Ventilation-Perfusion Ratio | 1983 |
Electroencephalographic observations in patients with chronic obstructive lung disease (COLD) treated with almitrine, a new respiratory analeptic agent.
Topics: Almitrine; Blood Gas Analysis; Electroencephalography; Female; Humans; Lung Diseases, Obstructive; Male; Piperazines; Triazines | 1980 |
[Pharmacokinetics of almitrine].
Topics: Administration, Oral; Almitrine; Humans; Infusions, Parenteral; Kinetics; Lung Diseases, Obstructive; Piperazines | 1980 |
[Respiratory stimulants and COPD].
Topics: Almitrine; Antidepressive Agents, Tricyclic; Carbonic Anhydrase Inhibitors; Clinical Trials as Topic; Double-Blind Method; Humans; Lung Diseases, Obstructive; Progestins; Respiratory Function Tests | 1994 |
Chronic respiratory failure in COPD: is there a place for a respiratory stimulant?
Topics: Almitrine; Antidepressive Agents, Tricyclic; Carbonic Anhydrase Inhibitors; Chronic Disease; Humans; Lung Diseases, Obstructive; Medroxyprogesterone Acetate; Respiratory Insufficiency; Theophylline | 1993 |
[An improvement in the hypoxemia after almitrine treatment in patients with chronic obstructive pulmonary diseases].
Topics: Aged; Almitrine; Drug Evaluation; Female; Humans; Hypoxia; Lung Diseases, Obstructive; Male; Middle Aged; Remission Induction | 1993 |
[Almitrine bismesylate in chronic obstructive pulmonary disease].
Topics: Almitrine; Humans; Lung Diseases, Obstructive | 1993 |
[The effects of almitrine bismesylate in chronic obstructive pulmonary disease with CO2 retention].
Topics: Aged; Almitrine; Carbon Dioxide; Female; Humans; Hypercapnia; Hypoventilation; Lung Diseases, Obstructive; Male; Middle Aged; Partial Pressure; Respiratory Function Tests; Respiratory Insufficiency | 1990 |
Evolution of peripheral nerve function in hypoxaemic COPD patients taking almitrine bismesylate: a prospective long-term study.
Topics: Aged; Almitrine; Humans; Lung Diseases, Obstructive; Middle Aged; Peripheral Nerves; Peripheral Nervous System Diseases; Piperazines; Prospective Studies; Synaptic Transmission | 1987 |
Almitrine in chronic airflow obstruction.
Topics: Almitrine; Humans; Lung Diseases, Obstructive; Piperazines | 1985 |
Peripheral neuropathy in patients treated with almitrine dimesylate.
Topics: Aged; Almitrine; Biopsy; Body Weight; Central Nervous System Stimulants; Drug Therapy, Combination; Evoked Potentials; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Neural Conduction; Peripheral Nervous System Diseases; Peroneal Nerve; Piperazines; Secologanin Tryptamine Alkaloids; Time Factors; Yohimbine | 1985 |
[Experimental and clinical bases for the respiratory action of almitrine].
Topics: Almitrine; Animals; Central Nervous System Stimulants; Humans; Lung; Lung Diseases, Obstructive; Piperazines; Respiration | 1986 |
Is chronic hypoxaemia and/or hypercapnia of the obstructive patient reversible? The role of almitrine bismesylate.
Topics: Almitrine; Central Nervous System Stimulants; Humans; Hypercapnia; Hypoxia; Lung Diseases, Obstructive; Piperazines | 1986 |
Undetermined utility of almitrine.
Topics: Almitrine; Central Nervous System Stimulants; Heart; Humans; Lung; Lung Diseases, Obstructive; Physical Exertion; Piperazines; Respiration | 1987 |
Platypnea induced by worsening of VA/Q inhomogeneity in the sitting position in chronic obstructive lung disease.
Topics: Aged; Almitrine; Central Nervous System Stimulants; Dyspnea; Humans; Hypoxia; Lung Diseases, Obstructive; Male; Piperazines; Posture; Ventilation-Perfusion Ratio | 1988 |
[Treatment of nocturnal hypoxia in chronic obstructive bronchopneumopathies].
Topics: Almitrine; Central Nervous System Stimulants; Humans; Hypoxia; Lung Diseases, Obstructive; Oxygen; Oxygen Inhalation Therapy; Piperazines; Pulmonary Circulation; Ventilation-Perfusion Ratio | 1988 |
[Lung function and blood gas analysis studies in patients with COPD and respiratory insufficiency receiving almitrine medication with special reference to its clinical aspects].
Topics: Almitrine; Central Nervous System Stimulants; Humans; Lung Diseases, Obstructive; Oxygen; Piperazines; Respiratory Function Tests; Respiratory Insufficiency | 1988 |
[Peripheral neuropathy in chronic bronchopathy. A study of 128 patients].
Topics: Aged; Almitrine; Central Nervous System Stimulants; Evoked Potentials, Somatosensory; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Neural Conduction; Peripheral Nervous System Diseases; Piperazines | 1988 |
Almitrine decreases compliance of pulmonary arteries in COPD.
Topics: Almitrine; Central Nervous System Stimulants; Humans; Lung Diseases, Obstructive; Piperazines; Pulmonary Artery | 1988 |
Peripheral neuropathy during treatment with almitrine.
Topics: Almitrine; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Peripheral Nervous System Diseases; Piperazines | 1985 |
Ten cases of peripheral neuropathy during treatment with almitrine in COPD patients.
Topics: Aged; Almitrine; Electromyography; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Peripheral Nervous System Diseases; Piperazines | 1986 |
The effects of almitrine at rest and on exercise in COPD patients.
Topics: Aged; Almitrine; Carbon Dioxide; Humans; Lung; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen; Physical Exertion; Piperazines | 1986 |
[Treatment of hematosis disorders in chronic obstructive bronchitis with almitrine bismesilate].
Topics: Almitrine; Bronchitis; Humans; Lung Diseases, Obstructive; Piperazines | 1987 |
Action of almitrine bismesylate on ventilation-perfusion matching in cats and dogs with part of the lung hypoventilated.
Topics: Almitrine; Animals; Cats; Dogs; Lung Diseases, Obstructive; Oxygen; Piperazines; Pulmonary Circulation; Species Specificity; Vascular Resistance; Ventilation-Perfusion Ratio | 1986 |
[Current knowledge and future perspectives on almitrine dimesylate (Vectarion). 8th International Pneumo-Allergology Seminar in Montpellier (21-24 May 1985)].
Topics: Almitrine; Animals; Humans; Lung Diseases, Obstructive; Piperazines | 1985 |
[Nocturnal hypoxemia of chronic obstructive bronchopathies and almitrine dimesylate].
Topics: Almitrine; Humans; Hypoxia; Lung Diseases, Obstructive; Piperazines; Sleep; Ventilation-Perfusion Ratio | 1985 |
[Future prospects concerning the clinical application and clinical pharmacology of almitrine dimesylate].
Topics: Almitrine; Aorta; Bronchitis; Carotid Body; Chemoreceptor Cells; Humans; Hypoxia; Lung; Lung Diseases, Obstructive; Oxygen Inhalation Therapy; Piperazines; Ventilation-Perfusion Ratio | 1985 |
[Almitrine in daily practice].
Topics: Almitrine; Bronchitis; Carbon Dioxide; Dyspnea; Hemodynamics; Humans; Lung Diseases, Obstructive; Oxygen; Piperazines; Pneumonia; Respiratory Insufficiency | 1985 |